drugset / Trial / NCT01298102

Influenza A/H1N1/2009-adjuvanted Vaccine in Renal Disease Patients

NCT01298102

Phase 4 Completed 185 enrolled Erasme University Hospital
NaSingle-groupOpen-labelPrevention

Summary

In 2009, the pandemic influenza A/H1N1 accounted for worldwide recommendations about vaccination. There is no data concerning the immunogenicity nor the security of the adjuvanted-A/H1N1 vaccine in renal disease patients. The aim of this study is to observe the effects of this vaccine on transplanted and hemodialyzed patients.

Timeline

Start
2009-10
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Pandemrix Vaccine Intramuscular